Works matching IS 13520504 AND DT 2020 AND VI 27 AND IP 3


Results: 13
    1

    Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 270, doi. 10.1111/jvh.13232
    By:
    • McDonald, Scott A.;
    • Pollock, Kevin G.;
    • Barclay, Stephen T.;
    • Goldberg, David J.;
    • Bathgate, Andrew;
    • Bramley, Peter;
    • Dillon, John F.;
    • Fraser, Andrew;
    • Innes, Hamish A.;
    • Kennedy, Nicholas;
    • Morris, Judith;
    • Went, April;
    • Hayes, Peter C.;
    • Hutchinson, Sharon J.
    Publication type:
    Article
    2
    3

    Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐ and post‐universal access to direct‐acting antiviral treatment in Australia: The LiveRLife study.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 281, doi. 10.1111/jvh.13233
    By:
    • Bajis, Sahar;
    • Grebely, Jason;
    • Hajarizadeh, Behzad;
    • Applegate, Tanya;
    • Marshall, Alison D.;
    • Ellen Harrod, Mary;
    • Byrne, Jude;
    • Bath, Nicky;
    • Read, Phillip;
    • Edwards, Michael;
    • Gorton, Carla;
    • Hayllar, Jeremy;
    • Cock, Victoria;
    • Peterson, Steven;
    • Thomson, Claire;
    • Weltman, Martin;
    • Jefferies, Meryem;
    • Wood, William;
    • Haber, Paul;
    • Ezard, Nadine
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 221, doi. 10.1111/jvh.13136
    Publication type:
    Article
    13